Literature DB >> 34754226

Characteristics of Myocardial Perfusion in Type 2 Diabetes Mellitus and Its Association with Left Ventricular Diastolic Dysfunction: A Study of Myocardial Contrast Echocardiography.

Yi Liu1, Jing Ma2, Jia Guo1, Hao Lu3, Yan Zhang1, Yilei Chen3.   

Abstract

BACKGROUND: Diabetic cardiomyopathy (DCM) will gradually progress to heart failure without intervention. The timely identification of left ventricular diastolic dysfunction (LVDD) in the early stage and active intervention helps delay the onset of heart failure. Although myocardial contrast echocardiography (MCE) allows an accurate evaluation of myocardial perfusion (MP), the characteristics of MP in early-stage or even sub-clinical LVDD are still unclear.
OBJECTIVE: This study aims to reveal the characteristics of MP in asymptomatic and normotensive patients with type 2 diabetes mellitus (T2DM) using MCE and investigate its association with LVDD development.
METHODS: A total of 327 T2DM patients were retrospectively analyzed. Patients diagnosed with LVDD were included in the LVDD+ group (n = 76), and those with normal left ventricular diastolic function were included in the LVDD- group (n = 251). The clinical characteristics, general echocardiographic findings, and MCE parameters were compared between the two groups. The accuracy of MCE parameters in the diagnosis of LVDD and their correlations with characteristics of T2DM were evaluated.
RESULTS: In the LVDD+ group, the A×β (derived from the replenishment curve of MCE, presenting myocardial blood flow) was significantly lower, and the HbA1c and diabetes duration were significantly higher compared to the LVDD- group (all P < 0.05). The decrease of A×β helped warn the occurrence of LVDD although it was not suitable for the independent diagnosis of LVDD (AUC = 0.745). A×β was negatively correlated with diabetes duration and HbA1c (r = -0.350 and -0.226, both P < 0.001).
CONCLUSION: MCE was feasible for detecting MP abnormalities in asymptomatic T2DM patients. Although the A×β values of T2DM patients with subclinical LVDD were better than those with diagnosed LVDD, it impaired with the increase of HbA1c and diabetes duration. It suggested that MCE might be useful for monitoring glycemic control in T2DM patients with DCM.
© 2021 Liu et al.

Entities:  

Keywords:  HbA1c; diabetes duration; diabetic cardiomyopathy; left ventricular diastolic dysfunction; myocardial perfusion; type 2 diabetes mellitus

Year:  2021        PMID: 34754226      PMCID: PMC8572094          DOI: 10.2147/IJGM.S340642

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


  33 in total

1.  Standards of medical care in diabetes--2010.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

Review 2.  β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes.

Authors:  Yoshifumi Saisho
Journal:  World J Diabetes       Date:  2015-02-15

Review 3.  Diabetic Cardiomyopathy: Definition, Diagnosis, and Therapeutic Implications.

Authors:  Stefania Paolillo; Fabio Marsico; Maria Prastaro; Francesco Renga; Luca Esposito; Fabiana De Martino; Pierfrancesco Di Napoli; Immacolata Esposito; Antonio Ambrosio; Monica Ianniruberto; Rosa Mennella; Roberta Paolillo; Paola Gargiulo
Journal:  Heart Fail Clin       Date:  2019-04-05       Impact factor: 3.179

4.  Update on diabetic cardiomyopathy: inches forward, miles to go.

Authors:  Maggie N Tillquist; Thomas M Maddox
Journal:  Curr Diab Rep       Date:  2012-06       Impact factor: 4.810

Review 5.  Role of microangiopathy in diabetic cardiomyopathy.

Authors:  Adriana Adameova; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 6.  Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies.

Authors:  Christina Voulgari; Dimitrios Papadogiannis; Nicholas Tentolouris
Journal:  Vasc Health Risk Manag       Date:  2010-10-21

Review 7.  Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.

Authors:  Maura Knapp; Xin Tu; Rongxue Wu
Journal:  Acta Pharmacol Sin       Date:  2018-06-04       Impact factor: 6.150

8.  Heart failure prevalence, incidence, and mortality in the elderly with diabetes.

Authors:  Alain G Bertoni; W Gregory Hundley; Mark W Massing; Denise E Bonds; Gregory L Burke; David C Goff
Journal:  Diabetes Care       Date:  2004-03       Impact factor: 19.112

9.  Subclinical left ventricular diastolic dysfunction and incident type 2 diabetes risk: the Korean Genome and Epidemiology Study.

Authors:  Juri Park; Jin-Seok Kim; Seong Hwan Kim; Sunwon Kim; Sang Yup Lim; Hong-Euy Lim; Goo-Yeong Cho; Ki-Chul Sung; Jang-Young Kim; Inkyung Baik; Kwang Kon Koh; Jung Bok Lee; Seung Ku Lee; Chol Shin
Journal:  Cardiovasc Diabetol       Date:  2017-03-14       Impact factor: 9.951

10.  Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology.

Authors:  Richard M Cubbon; Brook Adams; Adil Rajwani; Ben N Mercer; Peysh A Patel; Guy Gherardi; Christopher P Gale; Phillip D Batin; Ramzi Ajjan; Lorraine Kearney; Stephen B Wheatcroft; Robert J Sapsford; Klaus K Witte; Mark T Kearney
Journal:  Diab Vasc Dis Res       Date:  2013-01-24       Impact factor: 3.291

View more
  1 in total

1.  Nomogram based on multimodal echocardiography for assessing the evolution of diabetic cardiomyopathy in diabetic patients with normal cardiac function.

Authors:  Yi Liu; Hao Lu; Yan Zhang; Mengjie Cai; Jia Guo; Xiaofen Ruan
Journal:  Front Cardiovasc Med       Date:  2022-09-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.